ScreenerHero
ILUIllumina, Inc.
XETRA · DE · Healthcare · Diagnostics & Research · illumina.com
185.24EUR+2.91%Mkt Cap: 30.40B $P/E: 40.36

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and arr…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8

Key Statistics

Company
Market Cap30.40B $
Enterprise Value31.02B $
Revenue (TTM)4.88B $
Gross Profit3.12B $
Net Income (TTM)923.91M $
Revenue/Share32.14 USD
Last Price185.24 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8.6K
CountryDE
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)40.36
P/E (Forward)—
PEG2.69
EV/EBITDA24.71
EV/Revenue6.35
P/S6.05
P/B11.06
EPS (TTM)4.63
EPS (Forward)—
52W Range
163.74100% of range185.24
52W High185.24 EUR
52W Low163.74 EUR
Profitability
Gross Margin66.08%
Oper. Margin21.14%
EBITDA Margin25.70%
Profit Margin19.57%
ROE31.22%
ROA12.79%
Growth
Revenue Growth9.40%
Earnings Growth-9.40%
Cash Flow & Leverage
Operating CF1.17B $
CapEx (TTM)160.87M $
FCF Margin17.75%
FCF Yield2.85%
Net Debt1.48B $
Net Debt/EBITDA1.18
Balance Sheet
Debt/Equity0.94
Current Ratio1.80
Quick Ratio1.25
Book Value/Sh16.28 EUR
Cash/Share7.735 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.151.00M
Float148.48M
Insiders0.21%
Institutions105.90%
Technical
SMA 50151.92 (+21.9%)
SMA 200118.41 (+56.4%)
Beta1.46
S&P 52W Chg18.16%
Avg Vol (30d)66
Avg Vol (10d)49
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—